Profiel
Jean-Francois H.
Geschwind is associated with two companies, Sentient Technology, Inc. and Cage Pharma, Inc. He is the founder of both companies.
Sentient Technology, Inc. was founded in 2008, and no title is mentioned for him.
Cage Pharma, Inc. is also founded in 2008, and he holds the title of Chief Executive Officer & Director, which he still holds.
Actieve functies van Jean-Francois H. Geschwind
| Bedrijven | Functie | Begin |
|---|---|---|
Cage Pharma, Inc.
 Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Oprichter | 24-10-2008 |
Eerdere bekende functies van Jean-Francois H. Geschwind
| Bedrijven | Functie | Einde |
|---|---|---|
Sentient Technology, Inc.
 Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Health Technology |
Sentient Technology, Inc.
Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Health Technology |
